European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. [electronic resource]
- Leukemia 04 2020
- 966-984 p. digital
Publication Type: Journal Article; Review
1476-5551
10.1038/s41375-020-0776-2 doi
Aniline Compounds--therapeutic use Antineoplastic Agents--therapeutic use Clinical Decision-Making Consensus Development Conferences as Topic Dasatinib--therapeutic use Disease Management Fusion Proteins, bcr-abl--antagonists & inhibitors Gene Expression Humans Imatinib Mesylate--therapeutic use Leukemia, Myelogenous, Chronic, BCR-ABL Positive--diagnosis Life Expectancy--trends Monitoring, Physiologic Nitriles--therapeutic use Protein Kinase Inhibitors--therapeutic use Pyrimidines--therapeutic use Quality of Life Quinolines--therapeutic use Survival Analysis